Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001209191-23-002148

Options or other derivatives

  • Chief Medical Officer acquired 69,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Whiting Samuel Chief Medical Officer 2023-01-03 Grant or award · Employee Stock Option (right to buy) +69,700 69,700 D
Loading xslF345X03/doc4.xml…